Histologic and combined histologic-endoscopic outcomes with mirikizumab in Crohn's disease: VIVID-1 trial results. Jairath V, Magro F, Protic M, De Hertogh G, et al. J Crohns Colitis 2026;20:jjag077.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jairath V, Magro F, Protic M, De Hertogh G, et al. Histologic and combined histologic-endoscopic outcomes with mirikizumab in Crohn's disease: VIVID-1 trial results. J Crohns Colitis 2026;20:jjag077.
PMID: 42309525